Department of Molecular Biology and Plant Virology, Institute of Biomaterials and Biomolecular Systems, University of Stuttgart, Pfaffenwaldring 57, 70569 Stuttgart, Germany.
Institute of Interfacial Process Engineering and Plasma Technology IGVP, University of Stuttgart, Nobelstr. 12, 70569 Stuttgart, Germany.
Adv Drug Deliv Rev. 2019 May;145:96-118. doi: 10.1016/j.addr.2018.08.011. Epub 2018 Aug 31.
Nanomaterials composed of plant viral components are finding their way into medical technology and health care, as they offer singular properties. Precisely shaped, tailored virus nanoparticles (VNPs) with multivalent protein surfaces are efficiently loaded with functional compounds such as contrast agents and drugs, and serve as carrier templates and targeting vehicles displaying e.g. peptides and synthetic molecules. Multiple modifications enable uses including vaccination, biosensing, tissue engineering, intravital delivery and theranostics. Novel concepts exploit self-organization capacities of viral building blocks into hierarchical 2D and 3D structures, and their conversion into biocompatible, biodegradable units. High yields of VNPs and proteins can be harvested from plants after a few days so that various products have reached or are close to commercialization. The article delineates potentials and limitations of biomedical plant VNP uses, integrating perspectives of chemistry, biomaterials sciences, molecular plant virology and process engineering.
由植物病毒成分构成的纳米材料正在进入医疗技术和保健领域,因为它们具有独特的性质。精确成型、具有多价蛋白表面的定制病毒纳米颗粒(VNPs)可以有效地装载功能化合物,如对比剂和药物,并作为载体模板和靶向载体,展示例如肽和合成分子。多种修饰使其可用于疫苗接种、生物传感、组织工程、活体输送和治疗诊断。新的概念利用病毒构建块的自组织能力形成层次化的 2D 和 3D 结构,并将其转化为生物相容性、可生物降解的单元。VNPs 和蛋白质可以在几天内从植物中大量收获,因此各种产品已经或即将商业化。本文综合化学、生物材料科学、分子植物病毒学和过程工程的观点,阐述了生物医学植物 VNP 应用的潜力和局限性。